Showing results (121-130 of 323) with videos related to
Sort By:
Pageof 33
Archives of Biochemistry and Biophysics|July 1, 1985
Effect of glycerol on protein acetylation by acetic anhydrideA T Fojo, P M Reuben, P L Whitney, et al.Cancer Treatment Reports|February 1, 1983
Repeated femoral vein cannulation for administration of chemotherapeutic agentsB D Nidus, J L Speyer, J Bottino, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1985
4'Epidoxorubicin (epirubicin): activity in hepatocellular carcinomaH S Hochster, M D Green, J Speyer, et al.Cancer Chemotherapy and Pharmacology|January 1, 1997
Resistance to paclitaxel mediated by P-glycoprotein can be modulated by changes in the schedule of administrationZ Zhan, S Scala, A Monks, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 29, 1998
[Incidence of mutation and deletion in topoisomerase II mRNA of etoposide and m-AMSA resistant cell lines]Y Matsumoto, K Morisaki, K Kunishio, et al.Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
m-AMSA: a new anticancer agentM Rozencweig, D D Von Hoff, S S Legha, et al.American Journal of Clinical Oncology|December 1, 1984
Phase II trial of cyclophosphamide and cis-platinum for non-small cell bronchogenic carcinomaA M Schmidt, R H Blum, M Clayton, et al.Cancer|July 1, 1976
De novo Kaposi's sarcoma in renal transplantation. Case report and brief reviewM A Hardy, P Goldfarb, S Levine, et al.Oncogene|June 29, 2000
Paclitaxel selects for mutant or pseudo-null p53 in drug resistance associated with tubulin mutations in human cancerP Giannakakou, G Poy, Z Zhan, et al.Cancer Research|July 26, 2000
Loss of cell cycle control allows selective microtubule-active drug-induced Bcl-2 phosphorylation and cytotoxicity in autonomous cancer cellsM V Blagosklonny, P C Bishop, R Robey, et al.Pageof 33